USD 3.99
(2.84%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 22 Thousand USD | -98.17% |
2022 | 1.2 Million USD | -85.0% |
2021 | 8 Million USD | -21.41% |
2020 | 10.18 Million USD | -24.62% |
2019 | 13.5 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 Q2 | 2.26 Million USD | -46.07% |
2023 Q3 | 600 Thousand USD | -73.51% |
2023 Q1 | 4.2 Million USD | 250.0% |
2023 FY | 22 Thousand USD | -98.17% |
2023 Q4 | 22 Thousand USD | -96.33% |
2022 Q3 | 1.58 Million USD | -24.33% |
2022 Q4 | 1.2 Million USD | -24.48% |
2022 FY | 1.2 Million USD | -85.0% |
2022 Q1 | 8.59 Million USD | 7.45% |
2022 Q2 | 2.1 Million USD | -75.57% |
2021 Q3 | 9.49 Million USD | -13.64% |
2021 FY | 8 Million USD | -21.41% |
2021 Q4 | 8 Million USD | -15.72% |
2021 Q2 | 10.99 Million USD | 30.6% |
2021 Q1 | 8.41 Million USD | -17.33% |
2020 FY | 10.18 Million USD | -24.62% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 10.18 Million USD | 0.0% |
2019 FY | 13.5 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 100.0% |
Allurion Technologies Inc. | 2.3 Million USD | 99.046% |
Artivion, Inc. | 305.53 Million USD | 99.993% |
Avanos Medical, Inc. | 159.4 Million USD | 99.986% |
Butterfly Network, Inc. | 22.83 Million USD | 99.904% |
Butterfly Network, Inc. | 22.83 Million USD | 99.904% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 99.998% |
Boston Scientific Corporation | 8.96 Billion USD | 100.0% |
CONMED Corporation | 971.48 Million USD | 99.998% |
Edwards Lifesciences Corporation | 670 Million USD | 99.997% |
Paragon 28, Inc. | 109.79 Million USD | 99.98% |
Glaukos Corporation | 383.73 Million USD | 99.994% |
Globus Medical, Inc. | 417.4 Million USD | 99.995% |
Inspire Medical Systems, Inc. | 24.84 Million USD | 99.911% |
Integer Holdings Corporation | 959.92 Million USD | 99.998% |
Medtronic plc | 23.87 Billion USD | 100.0% |
Myomo, Inc. | 115.16 Thousand USD | 80.896% |
Nevro Corp. | 211.47 Million USD | 99.99% |
Penumbra, Inc. | 220.9 Million USD | 99.99% |
Vicarious Surgical Inc. | 13.78 Million USD | 99.84% |
Smith & Nephew plc | 2.17 Billion USD | 99.999% |
STERIS plc | 3.12 Billion USD | 99.999% |
Stryker Corporation | 10.9 Billion USD | 100.0% |
Vapotherm, Inc. | 109.97 Million USD | 99.98% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 100.0% |